BORGESON JOHN A. sold $142K of KOD
BORGESON JOHN A. (Chief Financial Officer) sold 4,104 shares of Kodiak Sciences Inc. (KOD) at $34.67 ($0.14M total) on 2026-06-04 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure may slightly influence short-term sentiment, but it does not introduce new information about Kodiak’s pipeline, finances, or regulatory status.
Market read
Traders may monitor for follow-on insider activity, but the 10b5-1 structure reduces the signal strength versus unscheduled selling.
What to watch
Check whether there were multiple insider transactions around the same period or changes in other executives’ holdings; a single Form 4 sale is often noisy.
Background
SEC Form 4 reports an officer’s/direct holdings transaction; this one is an open-market sale by Kodiak Sciences CFO under a pre-arranged Rule 10b5-1 plan.
Ticker impact
Kodiak Sciences CFO John A. Borgeson sold 4,104 shares in an open-market transaction under a 10b5-1 plan, disclosed via SEC Form 4.
Low likelihood of a sustained price move; any impact is likely brief unless accompanied by other company-specific catalysts.
The filing is an ownership-change disclosure with a pre-arranged 10b5-1 plan; the article provides no new operational/clinical/financial catalyst beyond the sale details.
Market effects
Minimal; this is company-specific insider activity with no stated sector-wide development.
None indicated.
None indicated.
Counterpoint
Because the sale is explicitly under a 10b5-1 plan, it may reflect scheduled liquidity rather than bearish expectations.
Key entities
- issuerKodiak Sciences Inc.
Subject of the SEC Form 4 insider transaction disclosure.
- officerJohn A. Borgeson
CFO who executed the open-market sale under a 10b5-1 plan.